Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

838
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
838
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

611
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.1K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertension and left ventricular geometry: Diagnosis, prognosis, and management.

EXCLI journal·2026
Same author

Challenges in the diagnosis and management of hypertrophic cardiomyopathy and the promise of artificial intelligence.

Current problems in cardiology·2025
Same author

The Obesity Paradox of Cardiovascular Outcomes in Patients with Diabetes Mellitus.

Current diabetes reports·2025
Same author

The Role of Obesity as a Cardiac Disease Risk Factor in Patients with Type 2 Diabetes.

Current cardiology reports·2024
Same author

A Global Perspective on Socioeconomic Determinants of Cardiovascular Health.

The Canadian journal of cardiology·2024
Same author

Empagliflozin and Dapagliflozin Therapies Favorably Alter QRS-T Angle and Cardiac Repolarization Parameters in Patients with Heart Failure.

The Journal of innovations in cardiac rhythm management·2024

Related Experiment Video

Updated: Mar 15, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.1K

Current Perspectives on Left Ventricular Geometry in Systemic Hypertension.

Ahmet Afşin Oktay1, Carl J Lavie1, Richard V Milani1

  • 1Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA.

Progress in Cardiovascular Diseases
|September 11, 2016
PubMed
Summary

Hypertension causes left ventricular remodeling, altering heart geometry and increasing cardiovascular disease risk. Anti-hypertensive therapies can reverse these changes, reducing overall CVD risk.

Keywords:
Anti-hypertension therapyHypertensionLeft ventricular geometryLeft ventricular hypertrophyRemodeling

More Related Videos

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

4.9K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

928

Related Experiment Videos

Last Updated: Mar 15, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.1K
Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

4.9K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

928

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiovascular Imaging

Background:

  • Hypertension (HTN) is a major global health issue and a primary risk factor for cardiovascular disease (CVD) mortality.
  • Hemodynamic stress from HTN induces left ventricular (LV) remodeling, leading to abnormal LV geometry (e.g., concentric remodeling, LV hypertrophy).
  • LV geometric abnormalities are independent risk factors for CVD and serve as key outcomes in anti-HTN drug trials.

Purpose of the Study:

  • To review the intricate relationship between hypertension and left ventricular geometric changes.
  • To focus on the diagnostic strategies, epidemiology, pathophysiology, and prognostic impact of these changes.
  • To examine the effects of anti-hypertensive therapy on LV geometry and subsequent CVD risk reduction.

Main Methods:

  • Literature review of studies investigating hypertension and left ventricular geometry.
  • Analysis of diagnostic approaches, including imaging techniques.
  • Synthesis of epidemiological data, pathophysiological mechanisms, and prognostic implications.
  • Evaluation of clinical trial data on anti-hypertensive treatments and LV remodeling.

Main Results:

  • Hypertension is consistently linked to significant alterations in left ventricular geometry.
  • LV geometric abnormalities are established independent predictors of cardiovascular events.
  • Anti-hypertensive medications demonstrate efficacy in reversing or preventing adverse LV remodeling.
  • Therapeutic interventions targeting LV geometry contribute to CVD risk reduction.

Conclusions:

  • Hypertension-induced left ventricular geometric changes are critical determinants of cardiovascular risk.
  • Accurate diagnosis and monitoring of LV geometry are essential in hypertensive patients.
  • Effective anti-hypertensive therapy plays a vital role in mitigating LV remodeling and improving cardiovascular outcomes.